Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
Phase II Clinical Trial Evaluating the Safety and Efficacy of Fc-Modified Anti-CD154 mAB (TNX-1500) in Kidney Transplant Recipients
The primary objective is to investigate the safety and efficacy of TNX-1500, an FC-modified anti-CD154 mAb, in five kidney transplant recipients at 12 months.
Kidney TransplantKidney Transplant Failure and RejectionImmunosuppression+1 more
Ayman Al Jurdi, MDNCT07204080
Phase 1
Tolerance Through Mixed Chimerism (Sip-Tego)
This is an open-label, single-institution study to assess the safety and the efficacy of the Sip-Tego regimen for the induction of donor-specific immunologic u…
Kidney FailureTransplant Recipient (Kidney)Transplant Tolerance+2 more
Tatsuo Kawai, MD, PhDNCT06972069